Nashville’s Monogram Health announces $160 million Series B raise
Monogram Health, a Nashville-based kidney disease benefit management and care delivery company, has raised $160 million in a Series B funding.
That announcement comes a little more than a year after the company announced that it had raised $12 million in the past 15 months. The new funds will be used to accelerate business expansion.
The round was led by TPG Capital, the private equity platform of global alternative asset firm TPG, with participation from existing investors Frist Cressey Ventures and Norwest Venture Partners, as well as Humana Inc. and other notable national and regional strategic investors.
